Europex Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2003.
2003 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Europex Pharma Private Limited

Europex Pharma Private Limited, a struck off private limited company, was established on 13 January 2003 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24240MH2003PTC138653. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Avinash Vithal Daund (Additional Director), Uma Paul Kalekar (Director). Past directors included Harjeet Singh Kaberwal. Its latest AGM occurred on 24 August 2009, with the balance sheet filed on 31 March 2009. It is based at Flat No 1 Ground Floornariman Bldg Maharshi Road Opp Cooperage Band Stand, Mumbai, Maharashtra, 400021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24240MH2003PTC138653

  • Registration Number

    138653

  • Incorporation Date

    13 January 2003

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 23 Year, 1 Month
  • Last Filing with ROC 31 Mar 2009
Company report

Europex Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Europex Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Europex Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Avinash Vithal Daund Additional Director 14 Apr 2008 Current
Uma Paul Kalekar Director 13 Jan 2003 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 09 Aug 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Europex Pharma.

Enhance accessibility to Europex Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Europex Pharma revenue growth over time
Europex Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Europex Pharma?

Unlock access to Europex Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Europex Pharma?

Unlock and access historical data on people associated with Europex Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Europex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Europex Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Europex Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Europex Pharma Private Limited last Annual general meeting of members was held on 24 Aug 2009 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Europex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2009 with Roc Mumbai. was completed.

  • Director Appointment

    Progress on Avinash Vithal Daund was appointed as a Additional Director was appointed as a Additional Director on 14 Apr 2008 & has been associated with this company since 17 years 10 months . was documented.

  • Director Appointment

    Uma Paul Kalekar was appointed as a Director was appointed as a Director on 13 Jan 2003 & has been associated with this company since 23 years 1 month . was recorded as a recent event.

  • Company Incorporation

    The activity Europex Pharma Private Limited was registered on 13 Jan 2003 with Roc Mumbai & aged 23 years 1 month as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Europex Pharma Private Limited?

The CIN of Europex Pharma Private Limited is U24240MH2003PTC138653.

Where is Europex Pharma Private Limited headquartered?

Europex Pharma Private Limited is headquartered at Flat No 1 Ground Floornariman Bldg Maharshi Road Opp Cooperage Band Stand, Mumbai, Maharashtra, 400021.

When was Europex Pharma Private Limited incorporated?

Europex Pharma Private Limited was incorporated on 13 January 2003.

Who are the current directors of Europex Pharma Private Limited?

The current directors of Europex Pharma Private Limited are

What is the primary industry of Europex Pharma Private Limited?

The primary industry of Europex Pharma Private Limited is Chemicals.

Is Europex Pharma Private Limited a listed company?

Europex Pharma Private Limited is unlisted.

What is the capital structure of Europex Pharma Private Limited?

The authorized capital of Europex Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available